C4 Therapeutics
Latest round
- Series B
Last raised
- May 2020
Total raised
- $220M
Investors
- 24
About C4 Therapeutics
C4 Therapeutics, Inc.Founded in 2016 and headquartered in Watertown, US, C4 Therapeutics, Inc. specializes in developing targeted therapies.40 mn.60 million shares at USD 19 per share.C4 Therapeutics specializes in innovative therapeutic solutions centered on Targeted Protein Degradation (TPD), particularly through its proprietary TORPEDO® platform. Their investigational drugs, including Cemsidomide, CFT8919, and CFT1946, focus on selectively degrading disease-causing proteins to address unmet needs in oncology and serious diseases. The company’s offerings aim to improve patient outcomes by minimizing off-target effects typical of conventional therapies.76 mn.C4 Therapeutics plans to leverage the proceeds from its recent IPO to advance multiple degrader drug candidates to human proof-of-concept, thereby enhancing its development pipeline. The company aims to expand its market presence, particularly in North America and Europe, as it works to bring new products to market.
Who invested in C4 Therapeutics
24 investors across 2 rounds
See all investors in C4 Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about C4 Therapeutics
Who invested in C4 Therapeutics?
C4 Therapeutics has 24 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has C4 Therapeutics raised?
C4 Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did C4 Therapeutics last raise money?
C4 Therapeutics's most recent round on record is a Series B, in May 2020.
What does C4 Therapeutics do?
C4 Therapeutics is a biotechnology company.
Where is C4 Therapeutics headquartered?
C4 Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like C4 Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at C4 Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like C4 Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.